Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Dollar on Back Foot as Omicron Optimism Grows

Published 09/12/2021, 10:18
Updated 09/12/2021, 10:18
© Reuters.

By Peter Nurse

Investing.com - The dollar edged higher Thursday, but remained on the back foot as risk appetite remained strong on positive news surrounding the likely economic damage caused by the Omicron Covid variant.

At 2:55 AM ET (0755 GMT), the Dollar Index, which tracks the greenback against a basket of six other currencies, rose 0.2% to 96.037, some way below the year’s high of approaching 97 seen at the end of November.

USD/JPY fell 0.1% to 113.53, EUR/USD slipped 0.2% to 1.1324, just below a one-week high, and the risk-sensitive AUD/USD gained 0.1% to 0.7176, just off its weekly high.

GBP/USD dropped 0.1% to 1.3203, after falling to a 2021 low on Wednesday after U.K. Prime Minister Boris Johnson imposed tougher Covid-19 restrictions in England, ordering people to work from home and wear masks in public places. Social gatherings will still be allowed, however. It has been politically impossible to restrict them due to public outrtage over a party held last Christmas by staff at 10 Downing Street in defiance of the government's own social distancing rules 

Despite this news out of England, risk-friendly currencies have seen demand this week following indications that the worst fears associated with the new Covid variant may not be realised.

Pfizer (NYSE:PFE) said on Wednesday that three doses of its Covid-19 vaccine, developed with BioNTech, neutralised the new Omicron variant in a laboratory test, indicating that booster shots could be key to protection against infection.

"We have highly effective vaccines that have proved effective against all the variants so far, in terms of severe disease and hospitalisation, and there's no reason to expect that it wouldn't be so" for Omicron, Mike Ryan, the World Health Organisation's emergencies director said Wednesday.

With the uncertainty surrounding the Omicron variant beginning to dissipate, attention is turning back to central banks and how they tackle the conflict between confronting high inflation and ensuring growth continues.

The Federal Reserve is still widely expected to announce it will accelerate tapering of its bond-buying program at its meeting next week, but last week’s nonfarm payrolls release disappointed.

Traders will likely keep a watchful eye on the release of the latest weekly U.S. jobless claims data, at 8:30 AM ET (1330 GMT), the most up-to-date gauge of the strength of the country’s labor market.

Elsewhere, USD/CAD rose 0.1% to 1.2659 after the Bank of Canada held its key overnight interest rate at 0.25% on Wednesday, as expected, and maintained its guidance that a first hike could come as soon as April 2022.

USD/PLN rose 0.1% to 4.0680 after Poland’s central bank raised its key interest rate by 50 basis points to 1.75%, as it battles the fastest inflation in two decades.     

USD/CNY was largely unchanged at 6.3435 after the People’s Bank of China tried to rein in its buoyant currency, setting its reference rate for the yuan at a weaker-than-expected level against the dollar.

USD/HUF rose 0.1% to 322.22 ahead of Thursday’s meeting of Hungary’s central bank, which is expected to deliver its fifth interest rate hike in a month in an attempt to combat inflation running at the fastest pace in 14 years.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.